HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

glutamylalanine

Also Known As:

Glu-Ala

Networked: 7 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - Dipeptides: 945
      - glutamylalanine: 7

Experts

1.	Al-Enazi, Nouf Mohammed: 1 article (07/2020)
2.	Adriouach, S: 1 article (01/2018)
3.	Allémann, E: 1 article (01/2018)
4.	Babič, A: 1 article (01/2018)
5.	Herceg, V: 1 article (01/2018)
6.	Janikowska, K: 1 article (01/2018)
7.	Lange, N: 1 article (01/2018)
8.	Chalé, Angela: 1 article (10/2014)
9.	Fielding, Roger A: 1 article (10/2014)
10.	Lustgarten, Michael S: 1 article (10/2014)

Related Diseases

1.	Breast Neoplasms (Breast Cancer) 01/01/2018 - "Glu-ALA-Hex produces similar levels of fluorescence as ALA-Hex in breast cancer MCF7 cells in vitro but with much lower non-specific cell toxicity." 04/01/2013 - "Overall, no significant associations were found between MTHFR Glu429Ala polymorphism and breast cancer risk when all studies were pooled into the meta-analysis (Glu/Glu vs Ala/Ala: OR = 0.891, 95 % CI = 0.782-1.015; Glu/Ala vs Ala/Ala: OR = 0.874, 95 % CI = 0.760-1.006; dominant model: OR = 0.885, 95 % CI = 0.775-1.012; and recessive model: OR = 0.989, 95 % CI = 0.931-1.051). " 04/01/2013 - "In the subgroup analysis by ethnicity, significantly elevated breast cancer risk was associated with Glu/Glu variant genotype in homozygote comparison and recessive genetic model (Glu/Glu vs Ala/Ala: OR = 0.78, 95 % CI = 0.63-0.97; Glu/Glu vs Glu/Ala: OR = 0.92, 95 % CI = 0.85-0.99; recessive model: OR = 0.91, 95 % CI = 0.85-0.97), while no significant associations were found for all comparison models in other ethnicity populations. "
2.	Neoplasms (Cancer) 05/01/2011 - "This study describes the radiosynthesis, in vitro and in vivo evaluation of the novel small peptide radioligand, 4-[(18)F]fluorobenzoyl-Phe-Ala-Leu-Gly-Glu-Ala-NH(2,) ([(18)F]FBA-FALGEA-NH(2)) as a positron emission tomography (PET) tracer for imaging of the cancer specific epidermal growth factor receptor (EGFR) variant III mutation, EGFRvIII. "
3.	Vascular System Injuries 10/01/2022 - "Ile-Ile-Ala-Val-Glu-Ala-Gly-Cys (IEC) is a novel octapeptide isolated from the microalgae, Isochrysis Zhanjiangensis that inhibits the vascular injury, angiogenesis and has a protective effect on cardiovascular diseases. "
4.	Leukemia 10/28/1997 - "For the avian leukemia virus protease substrate, Thr-Phe-Gln-Ala-FPhe-Pro-Leu-Arg-Glu-Ala, the cleavage was both slower and less specific. "
5.	Insulin Resistance 10/01/2014 - "Metabolites related to gut bacterial metabolism (cinnamoylglycine, phenol sulfate, p-cresol sulfate, 3-indoxyl sulfate, serotonin, N-methylproline, hydrocinnamate, dimethylglycine, trans-urocanate, valerate) that are altered in response to peroxisome proliferator-activated receptor-alpha (PPAR-α) activation (α-hydroxyisocaproate, α-hydroxyisovalerate, 2-hydroxy-3-methylvalerate, indolelactate, serotonin, 2-hydroxypalmitate, glutarylcarnitine, isobutyrylcarnitine, cinnamoylglycine) and that are related to insulin sensitivity (monounsaturated fatty acids: 5-dodecenoate, myristoleate, palmitoleate; γ-glutamylamino acids: γ-glutamylglutamine, γ-glutamylalanine, γ-glutamylmethionine, γ-glutamyltyrosine; branched-chain amino acids: leucine, isoleucine, valine) were associated with function at baseline, with the 6-month change in function or were identified in backward elimination regression predictive models. "

Related Drugs and Biologics

1.	ErbB Receptors (EGF Receptor)
2.	Peptides (Polypeptides)
3.	epidermal growth factor receptor VIII
4.	glutamyl-glutamic acid (Glu-Glu)
5.	phenylalanylalanine
6.	glycylleucine (Leu-Gly)
7.	alanylalanine (Ala-Ala)
8.	Wastewater
9.	PPAR alpha
10.	Peroxisome Proliferator-Activated Receptors (PPAR)